| Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283) |
|---|
| 07/07/2005 | US20050148780 Hydrolysis to produce 3-(5,5-Dimethyl-1,3-dioxan-2-yl)-1-(4-ethoxyphenyl)butan-1-one, as intermediates for producing a 4-methyl-1,2-diarylpyrrole derivative; simple and safe procedure in a high yield and purity product, not using nitromethane |
| 07/07/2005 | DE4404838B4 Reinigung von Lactiden durch Schmelz-Kristallisation Purification of lactides by melt-crystallization |
| 07/07/2005 | CA2548513A1 Biaryl sulfonamides and methods for using same |
| 07/07/2005 | CA2547575A1 Method for treating adamts-5-associated disease |
| 07/06/2005 | EP1550655A1 Bicyclic intermediates |
| 07/06/2005 | EP1549627A1 1-phenylalkyl-piperazines |
| 07/06/2005 | EP1549598A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif) |
| 07/06/2005 | EP1549306A1 Substituted phenylsulfonamide inhibitors of beta amyloid production |
| 07/06/2005 | EP1549283A1 Merocyanine derivatives for cosmetic use |
| 07/05/2005 | US6914160 Oxytocin inhibitors |
| 07/05/2005 | CA2344647C New derivatives of 6-(4-phenylbutoxy)hexylamine and process for producing salmeterol |
| 06/30/2005 | US20050143456 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/29/2005 | EP1546137A1 Benzimidazol-1-yl-thiophene compounds for the treatment of cancer |
| 06/29/2005 | EP1546116A1 Vanilloid receptor ligands and their use in treatments |
| 06/29/2005 | CN1208329C Aniline derivatives |
| 06/29/2005 | CN1208314C Factor VIIA inhibitor (thio) urea derivatives, their preparation and their use |
| 06/28/2005 | US6911560 Via isomerization catalyst |
| 06/24/2005 | CA2454456A1 Amino ceramide-like compounds and therapeutic methods of use |
| 06/23/2005 | WO2005056509A1 Purification process for lactide |
| 06/23/2005 | DE102004053281A1 New mesogenic S-perfluoroalkyl-sulfimide or -sulfoximide compounds, useful in liquid crystal and electro-optical display devices |
| 06/23/2005 | CA2552395A1 Purification process for lactide |
| 06/22/2005 | EP1544196A1 Process for the production of gamma-keto acetals |
| 06/22/2005 | EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 06/21/2005 | US6908935 Calcium receptor modulating agents |
| 06/21/2005 | CA2180010C 7-¬carboxyalkyl or alkenyl|-6-¬alkyl or alkenyl| 3-oxo-2,4-dioxobicyclo-¬3.2.1| octane and derivatives thereof |
| 06/16/2005 | US20050130973 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 06/16/2005 | DE4217248B4 Vinylverbindungen Vinyl compounds |
| 06/15/2005 | EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 06/15/2005 | CN1626526A Compound of alpha, beta and beta, gamma unsaturation carboxylate class of possessing weeding activity |
| 06/15/2005 | CN1206228C N-heterocyclic derivatives as NOS inhibitors |
| 06/14/2005 | US6906207 Nucleating agents for improving the optical properties; for food or cosmetic containers and packaging; as gelling agents for water and organic solvents used in the preparation of antiperspirant gel sticks |
| 06/14/2005 | US6906072 Central nervous system disorders |
| 06/14/2005 | CA2155952C Novel process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
| 06/09/2005 | WO2005051895A1 Organic compounds |
| 06/09/2005 | US20050124691 Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the same |
| 06/09/2005 | US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy |
| 06/09/2005 | US20050124641 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |
| 06/09/2005 | US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions |
| 06/08/2005 | EP1538150A1 Novel pleuromutilin derivatives |
| 06/08/2005 | EP1537096A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 06/08/2005 | EP1537085A1 Oxytocin inhibitors |
| 06/08/2005 | EP1276735B1 Method for purifying cyclic esters |
| 06/08/2005 | CN1623988A Biaryl sulfonamides and methods for using same |
| 06/08/2005 | CN1205213C Method for the production of imidazol-[1,2-c][2,3]-benzodiazepines and intermediates in production thereof |
| 06/08/2005 | CN1205201C Process for the preparation of cyclic lactic acid oligomers |
| 06/08/2005 | CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 06/08/2005 | CN1204892C Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid |
| 06/07/2005 | US6903225 Process for producing optically active 2-[6-(hydroxymethyl)-1,3-dioxan-4-yl]acetic acid derivatives |
| 06/01/2005 | EP1535921A1 Method of manufacture of 1,3-oxathiolane nucleosides |
| 06/01/2005 | EP1535909A2 Cyclic amine derivatives and their use as drugs |
| 06/01/2005 | EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 06/01/2005 | EP1534658A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 06/01/2005 | EP1351959B1 Novel pleuromutilin derivatives |
| 06/01/2005 | EP1248761A4 Compounds which mimic the chemical and biological properties of discodermolide |
| 06/01/2005 | EP0993441B1 INHIBITORS OF p38 |
| 06/01/2005 | CN1204144C Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/31/2005 | US6900345 Antibiotics; mutilin 14-[N-(2-carbamoyloxyethoxycarbonyl)]carbamate; therapy for bacteria infections; chemical synthesis |
| 05/26/2005 | WO2005047249A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 05/26/2005 | WO2005046683A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/26/2005 | US20050113580 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 05/26/2005 | US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid |
| 05/26/2005 | US20050113366 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |
| 05/26/2005 | CA2543913A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 05/26/2005 | CA2541949A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/25/2005 | EP1533308A2 A process for producing a simvastatin precursor |
| 05/25/2005 | EP1532095A1 Method for producing aldehydes by means of hydroformylation of olefinically unsaturated compounds, said hydroformylation being catalysed by unmodified metal complexes in the presence of cyclic carbonic acid esters |
| 05/25/2005 | EP1532094A1 Method for the hydroformylation of olefinically unsaturated compounds, especially olefins, in the presence of cyclic carbonic acid esters |
| 05/25/2005 | EP1341742B1 Method for producing compounds having a cf2o bridge |
| 05/25/2005 | EP1140814B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/19/2005 | WO2004072254A3 Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex |
| 05/19/2005 | WO2004064745A3 Method of preparation of heterocyclic molecules with pharmaceutical pharmaceutical excipient cosmeceutical agrochemical and industrial uses |
| 05/19/2005 | US20050107469 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 05/18/2005 | EP0998452B1 Liquid crystal propene or propenyl nitrile derivatives |
| 05/18/2005 | CN1617867A Process for preparation of ethyl 2, 3-dihydrobenzo [1, 4] dioxins -2-carboxylate |
| 05/18/2005 | CN1616450A Catalytic synthetic method for lactide |
| 05/18/2005 | CN1616417A Photo-stable cosmetic and pharmaceutical formulations containing UV-filters |
| 05/18/2005 | CN1202063C Method for preparing phenol compound derivated from dialoxy acetaldehyde and use |
| 05/17/2005 | US6894052 Serotonergic receptor antagonist |
| 05/12/2005 | WO2005042513A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase |
| 05/12/2005 | WO2005023793A3 Direct synthesis of di-heteroatom containing cyclic organic compounds |
| 05/12/2005 | WO2005014539A3 Pyrrole-based hmg-coa reductase inhibitors |
| 05/12/2005 | WO2004072087A3 Metal complexes as light-absorbing compounds in the information layer of optical data carriers |
| 05/12/2005 | US20050101644 Benzylether amine compounds useful as CCR-5 antagonists |
| 05/12/2005 | CA2540843A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase |
| 05/10/2005 | US6891048 Glycolide production process, and glycolic acid composition |
| 05/10/2005 | US6890959 Such as cis-(4-dimethylaminomethyl-3-hydroxy-3-(3-methoxy-phenyl)-cyclohexanone for treatment of pain, inflammation, allergies, depression, drug/alcohol abuse, gastritis, itching, cardiovascular/repiratory diseases, epilepsy, and diarrhea |
| 05/10/2005 | US6890949 Amino ceramide-like compounds and therapeutic methods of use |
| 05/10/2005 | US6890937 Inhibiting the activity of one or more of MMP-2, MMP-9 and MMP-13, while exhibiting substantially less inhibitory activity against MMP-1 |
| 05/06/2005 | WO2005040355A2 Tao kinase modulators and methods of use |
| 05/06/2005 | WO2005040138A1 Substituted benzylaminoalkylene heterocycles |
| 05/06/2005 | WO2005040127A1 Novel compounds as agonist for ppar gamma and ppar alpha, method for preparation of the same, and pharmaceutical composition containing the same |
| 05/06/2005 | CA2542695A1 Substituted benzylaminoalkylene heterocycles |
| 05/06/2005 | CA2542064A1 Tao kinase modulators and methods of use |
| 05/05/2005 | US20050096357 Antibiotics; therapy for infections which is caused by drug-resistant Streptococcus, or bacteria infections |
| 05/04/2005 | EP1527064A2 Preparation of lactic acid derivatives and their use |
| 05/04/2005 | CN1199967C Dioxy methane derivatives |
| 05/03/2005 | US6887865 N-heterocyclic derivatives as NOS inhibitors |
| 04/28/2005 | US20050090674 Process for the preparation of 2-(6-substituted-1,3-dioxane-4-yl) acetic acid derivates |
| 04/28/2005 | US20050090630 Supported group 8-10 transition metal olefin polymerization catalysts |